Odyssey Therapeutics, Inc. · NASDAQ:ODTX
James G. Coulter bought 1,388,889 Odyssey Therapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 13, 2026
On May 11, 2026, James G. Coulter (Former 10% Owner) bought 1,388,889 Odyssey Therapeutics, Inc. shares at US$18.00 for US$25M, leaving 3,690,146 shares. Filed May 13, 2026 (Form 4).
- Bought
- 1,388,889 shares
- Price
- US$18.00
- Value
- US$25M
- Holding after
- 3,690,146 shares (held indirectly)
- Trading plan
- No
- Role
- Former 10% Owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Other | 423,111 | 423,111 | Indirect | |
| May 11, 2026 | Common Stock | Other | 2,351 | US$18.00 | 420,760 | Indirect |
| May 11, 2026 | Common Stock | Conversion | 1,880,497 | 2,301,257 | Indirect | |
| May 11, 2026 | Common Stock | Buy | 1,388,889 | US$18.00 | 3,690,146 | Indirect |
Source
Related
- Odyssey Therapeutics, Inc.
- James G. Coulter
- Odyssey Therapeutics, Inc. shareholders
- Schedule 13G · FMR LLC · Jun 5, 2026
- Schedule 13D · SR One Capital Management, LLC · May 18, 2026
- Schedule 13D · Tpg Gp A, LLC · May 18, 2026
- Schedule 13G · Lightspeed Venture Partners XV-B (Ignite), L.P. · May 18, 2026
- Schedule 13D · Jeito II S.L.P. · May 15, 2026